Skip to main content

Table 5 Annual growth rates

From: Impact of orphan drugs on Latvian budget

Expenditure 2010–2011 2011–2012 2012–2013 2013–2014
Orphan drugs (all) 23.52 % 20.16 % −30.01 % 23.16 %
Orphan drugs (excl. Glivec) 47.73 % 70.67 % 23.00 % 23.16 %
Total pharmaceutical market 4.88 % 1.82 % 4.10 % 2.75 %
Total drug reimbursement budget 11.61 % −1.01 % 0.32 % 4.21 %